Showing posts with label Severe. Show all posts
Showing posts with label Severe. Show all posts

Wednesday, September 25, 2013

0 Differential Regulation of Inflammation and Immunity in Mild and Severe Experimental Asthma.



Mediators of Inflammation Volume 2013 (2013), Article ID 808470, 11 pages http://dx.doi.org/10.1155/2013/808470

Research Article

Differential Regulation of Inflammation and Immunity in Mild and Severe Experimental Asthma



1Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, P.O. Box 80082, 3508 TB Utrecht, The Netherlands
2Danone Research, Centre for Specialised Nutrition, 6704 PH Wageningen, The Netherlands


Received 14 January 2013; Revised 15 March 2013; Accepted 4 April 2013

Academic Editor: Alex Kleinjan


Copyright © 2013 Seil Sagar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.



Abstract


This study aimed at exploring innate and adaptive immunity in allergic asthma by investigation of mRNA expression of pattern recognition receptors, T-cell-specific cytokines, and transcription factors. Mouse models for mild and severe asthma, with similar pathological characteristics observed in humans, were used to study the involved inflammatory markers as a first step in the development of phenotype-directed treatment approaches. In the mild model, mice were sensitized to ovalbumin-Imject Alum and challenged with ovalbumin. In the severe model, mice were sensitized to trinitrophenyl-conjugated ovalbumin and challenged with trinitrophenyl-ovalbumin/IgE immune complex. Pulmonary airway inflammation and mRNA expression of Toll-like receptors (TLRs), NOD-like receptors (NLRs), T cell cytokines, and transcription factors in lung tissue were examined. Different mRNA expression profiles of TLRs, NLRs, T cell cytokines, and transcription factors were observed. In the mild model, Il10showed the largest increase in expression, whereas in the severe model, it was Infγ with the largest increase. Expression of Tbet was also significantly increased in the severe model. Inflammation and immunity are differentially regulated in mild and severe experimental asthma. This preclinical data may help in directing clinical research towards a better understanding and therapy in mild and severe asthmatic patients.



Friday, September 20, 2013

0 Severe contact dermatitis due to camomile: a common complementary remedy with potential sensitization risks

Open Access


Short report


Severe contact dermatitis due to camomile: a common complementary remedy with potential sensitization risks



Sibel Dogan












Allergy, Asthma & Clinical Immunology 2013, 9:26 doi:10.1186/1710-1492-9-26

Published: 15 July 2013





Abstract (provisional)


Camomile extracts and compositae mix containing herbal remedies are used for several alternative/complementary therapies for a long time. In fact, camomile has been used traditionally in eastern Anatolia as a pain relieving topical anesthetic agent. Besides becoming a popular herbal remedy, camomile is also known for its potential in inducing chemical burn, irritant and allergic contact dermatitis, conjunctivitis and anaphylaxis. Different clinical apperances of camomile allergy was reviewed with three patients using the same topical camomile remedy in this report. It is important to remember that home-made crushed camomile preparations can lead both sensitization and acute allergic contact dermatitis as well.






The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.



Tuesday, September 17, 2013

0 Severe dapsone hypersensitivity syndrome in a child













CASE REPORT

Korean J Pediatr 2013 June;56(6) :260-264.
Published online 2012 October 25.        doi:http://dx.doi.org/10.3345/kjp.2013.56.6.260



































Severe dapsone hypersensitivity syndrome in a child
So Yoon Choi1, Ho Yeon Hwang1, Jung Hyun Lee1, Jae Sun Park1, Min Soo Jang2
1Departments of Pediatrics Kosin University Gospel Hospital, Busan, Korea
2Departments of Dermatology, Kosin University Gospel Hospital, Busan, Korea
Corresponding Author: Jae Sun Park ,Tel: +82-51-990-6230, Fax: +82-51-990-3005, Email: pjs@ns.kosinmed.or.kr
Copyright © 2013 by The Korean Pediatric Society
Share :   
ABSTRACT
Dapsone (4,4′-diaminodiphenylsulfone, DDS), a potent anti-inflammatory agent, is widely used in the treatment of leprosy and several chronic inflammatory skin diseases. Dapsone therapy rarely results in development of dapsone hypersensitivity syndrome, which is characterized by fever, hepatitis, generalized exfoliative dermatitis, and lymphadenopathy. Here, we describe the case of an 11-year-old Korean boy who initially presented with high fever, a morbilliform skin rash, generalized lymphadenopathy, hepatosplenomegaly, and leukopenia after 6 weeks of dapsone intake. Subsequently, he exhibited cholecystitis, gingivitis, colitis, sepsis, aseptic meningitis, disseminated intravascular coagulation, syndrome of inappropriate antidiuretic hormone secretion, pneumonia, pleural effusions, peritonitis, bronchiectatic changes, exfoliative dermatitis, and acute renal failure. After 2 months of supportive therapy, and prednisolone and antibiotic administration, most of the systemic symptoms resolved, with the exception of exfoliative dermatitis and erythema, which ameliorated over the following 4 months. Agranulocytosis, atypical lymphocytosis, aseptic meningitis, and bronchiectatic changes along with prolonged systemic symptoms with exfoliative dermatitis were the most peculiar features of the present case.

Keywords: Aseptic meningitis | Bronchiectasis | Dapsone | Multiple organ failure







































TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Supplementary Material  Supplementary Material
  E-Mail